Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 3, 2010, Pages 167-177

  Frazier, Thomas W ^a   Youngstrom, Eric A ^b   Haycook, Travis ^a   Sinoff, Aletta ^a   Dimitriou, Francine ^a   Knapp, Julie ^a   Sinclair, Leslie ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATOMOXETINE; CLONIDINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; MOLINDONE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; VALPROATE SEMISODIUM; ZIPRASIDONE; CENTRAL NERVOUS SYSTEM AGENTS; TRANQUILIZER;

ADOLESCENT; AGGRESSION; AGGRESSIVENESS; ANALYSIS OF COVARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MALE; MOOD DISORDER; PRESCHOOL CHILD; PSYCHOSIS; SCHOOL CHILD; SLEEP DISORDER; SURVIVAL; ANALYSIS OF VARIANCE; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DRUG EFFECTS; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; AGGRESSION; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954934909     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0048     Document Type: Article

References (60)

1. Accardo P: Risperidone in children with autism and serious behavioral problems. J Pediatr 142:86-87, 2003.
2. Allik H, Larsson JO, Smedje H: Sleep patterns of school-age children with Asperger syndrome or high-functioning autism. J Autism Dev Disord 36:585-595, 2006. (Pubitemid 44336981)
3. Aman MG, Singh NN, Stewart AW, Field CJ: The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects. Am J Ment Defic 89:485-491, 1985.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DMS-IV). Washington (DC): American Psychiatric Association, 1994.
5. Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH: Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. Am J Psychiatry 141:11951202, 1984.
6. Belcher TL. Behavioral treatment vs. behavioral control: A case study. J Devel Phys Disabil 7:235-241, 1995.
7. Borenstein M, Rothstein H, Cohen J, Schoenfeld D, Berlin J: Power and Precision, 2.1 ed. New York: Biostat, Inc., 2001.
8. Canitano R: Self injurious behavior in autism: Clinical aspects and treatment with risperidone. J Neural Transm 113:425-431, 2006.
9. Carter AS, Black DO, Tewani S, Connolly CE, Kadlec MB, Tager-Flusberg H: Sex differences in toddlers with autism spectrum disorders. J Autism Dev Disord 37:86-97, 2007.
10. Chez MG, Memon S, Hung PC: Neurologic treatment strategies in autism: An overview of medical intervention strategies. Semin Pediatr Neurol 11:229-235, 2004.
11. Depp C, Lebowitz BD: Clinical trials: Bridging the gap between efficacy and effectiveness. Int Rev Psychiatry 19:531-539, 2007.
12. Dominick K, Davis N, Lainhart J, Tager-Flusberg H, Folstein S: Atypical behaviors in children with autism and children with a history of language impairment. Res Dev Disabil 28:145-162, 2007.
13. Eikeseth S, Smith T, Jahr E, Eldevik S: Intensive behavioral treatment at school for 4-to 7-year-old children with autism. A 1-year comparison controlled study. Behav Modif 26:49-68, 2002.
14. Eikeseth S, Smith T, Jahr E, Eldevik S: Outcome for children with autism who began intensive behavioral treatment between ages 4 and 7: A comparison controlled study. Behav Modif 32:264-278, 2007.
15. Eldevik S, Eikeseth S, Jahr E, Smith T: Effects of low intensity behavioral treatment for children with autism and mental retardation. J Autism Dev Disord 36:211-224, 2006.
16. Ernst E, Pittler MH: Efficacy or effectiveness? J Intern Med 260:488490, 2006.
17. Foxx RM, Meindl J: The long term successful treatment of the aggressive/destructive behaviors of a preadolescent with autism. Behav Intervent 22:83-97, 2007.
18. Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS: A simple and valid tool distinguished efficacy from effectiveness studies. J Clin Epidemiol 59:1040-1048, 2006.
19. Geschwind D. Autism: Searching for coherence. Biol Psychiatry 62:949-950, 2007.
20. Gobbi G, Pulvirenti L: Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behavior. J Psychiatry Neurosci 26:340-341, 2001.
21. Goin-Kochel R, Myers B, MacKintosh V: Parental reports on the use of treatments and therapies for children with autism spectrum disorders. Res Autism Spectr Disord 1:195-209, 2007.
22. Horrigan JP, Barnhill LJ: Risperidone and explosive aggressive autism. J Autism Dev Disord 27:313-323, 1997.
23. Howlin P, Magiati I, Charman T: Systematic review of early intensive behavior interventions for children with autism. Am J Intellect Develop Disabilities 114:23-41, 2009.
24. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T: Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr 22:60-73, 2001.
25. Kang J, Schafer JL: Demystifying double robustness: A comparison of alternative strategies for estimating population means from incomplete data. Statist Sci 26:523-539, 2007.
26. Kerbeshian J, Burd L, Randall T, Martsolf J, Jalal S: Autism, profound mental retardation and atypical bipolar disorder in a 33-year-old female with a deletion of 15q12. J Ment Defic Res 34(Pt 2): 205-210, 1990.
27. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M: Treatment guidelines for children and adolescents with bipolar disorder: Child Psychiatric Workgroup on Bipolar Disorder. J Am Acad Child Adolesc Psychiatry 44:213-235, 2005.
28. Kratochvil CJ, Findling RL, McDougle CJ, Scahill L, Hamarman S: Pharmacological management of agitation and aggression in an adolescent with autism. J Am Acad Child Adolesc Psychiatry 44:829-832, 2005.
29. Lee DO, Ousley OY: Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol 16: 737-746, 2006.
30. Lord C, Schopler E: Differences in sex ratios in autism as a function of measured intelligence. J Autism Dev Disord 15:185-193, 1985.
31. Lord C, Schopler E, Revicki D: Sex differences in autism. J Autism Dev Disord 12:317-330, 1982.
32. Lovaas OI: Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psy-chol 55:3-9, 1987.
33. Luby J, Mrakotsky C, Meade-Stalets M, Belden A, Heffelfinger A, Williams M, Spitznagel E: Risperidone in preschool children with autistic spectrum disorders: An investigation of safety and efficacy. J Child Adolesc Psychopharmacol 16:575-587, 2006.
34. MacDonald KM, Vancayzeele S, Deblander A, Abraham IL: Longitudinal observational studies to study the efficacy-effectiveness gap in drug therapy: Application to mild and moderate dementia. Nurs Clin North Am 41:105-117, vii, 2006.
35. Magiati I, Charman T, Howlin P: A two-year prospective follow-up stduy of community-based early intensive behavioral intervention and specialist nursery provision for children with autism spectrum disorders. J Child Psychol Psychiatry 48:803-812, 2007.
36. Malone RP, Silvia SS, Delaney MA, Hyman S: Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drugs 19:923-934, 2005.
37. Malow BA, Crowe C, Henderson L, McGrew SG, Wang L, Song Y, Stone WL: A sleep habits questionnaire for children with autism spectrum disorders. J Child Neurol 24:19-24, 2009.
38. March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J: The treatment for adolescents with depression study (TADS): Long-term effectiveness and safety outcomes. Arch Gen Psychiatry 64:1132-1143, 3.
39. Marshburn EC, Aman MG: Factorial validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation. J Autism Dev Disord 22:357-373, 1992.
40. Matson J, Benavidez D, Compton LS, Paclawskyj T, Baglio C: Behavioral treatment of autistic persons: A review of research from 1980 to the present. Res Dev Disabil 17:433-465, 1996.
41. Matson JL, Dixon DR, Matson ML: Assessing and treating aggression in children and adolescents with developmental disabilities: A 20-year overview. Educ Psychol 25:151-181, 2005.
42. Matson J, LoVullo S, Boisjoli J, Gonzalez M: The behavioral treatment of an 11-year old girl with autism and aggressive behaviors. Clin Case Stud 7:313-326, 2008.
43. McClellan J, Werry J: Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 36:157-176, 1997.
44. McClellan J, Kowatch R, Findling RL: Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 46:107-125, 2007.
45. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D: Ris-peridone in children with autism and serious behavioral problems. N Engl J Med 347:314-321, 2002.
46. McDougle C: Current and emerging therapeutics of autistic disorder and related pervasive developmental disorders. In: Neuropsycho-pharmacology: The Fifth Generation of Progress. Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Philadelphia: Lippincott Williams and Wilkins, 2002, pp 565-576.
47. McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B: Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 162:1142-1148, 2005.
48. Munesue T, Ono Y, Mutoh K, Shimoda K, Nakatani H, Kikuchi M: High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: A preliminary study of 44 outpatients. J Affect Disord 111:170-175, 4.
49. Posey DJ, Walsh KH, Wilson GA, McDougle CJ: Risperidone in the treatment of two very young children with autism. J Child Adolesc Psychopharmacol 9:273-276, 1999.
50. POTS: Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969-1976, 2004.
51. Prochaska JO, Evers KE, Prochaska JM, Van Marter D, Johnson JL: Efficacy and effectiveness trials: examples from smoking cessation and bullying prevention. J Health Psychol 12:170-178, 2007.
52. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70:41-55, 1983.
53. Rubin DB: Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 66:688-701, 1974.
54. Sanchez LE, Adams PB, Uysal S, Hallin A, Campbell M, Small AM: A comparison of live and videotape ratings: Clomipramine and haloperidol in autism. Psychopharmacol Bull 31:371-378, 1995.
55. Schafer JL, Graham JW: Missing data: Our view of the state of the art. Psycholog Methods 7:147-177, 2002.
56. Schafer JL, Kang J: Average causal effects from nonrandomized studies: A practical guide and simulated example. Psycholog Methods 13:279-313, 2008.
57. Tuchman R, Moshe SL, Rapin I: Convulsing toward the pathophysi-ology of autism. Brain Dev 31:95-103, 2009.
58. Vercellino F, Zanotto E, Ravera G, Veneselli E: Open-label risper-idone treatment of 6 children and adolescents with autism. Can J Psychiatry 46:559-560, 2001.
59. Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL: Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 165:335-341; quiz 409, 2008.
60. Youngstrom EA, Birmaher B, Findling RL: Pediatric bipolar disorder: Validity, phenomenology, and recommendations for diagnosis Bipolar Disord 10:194-214, 2008.